Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer

Anticancer Research

Volumn 17, Issue 3 C, 1997, Pages 2253-2258

  Endo, Kazuya ^a   Maehara, Yoshihiko ^b   Baba, Hideo ^c   Yamamoto, Manabu ^a   Tomisaki, Shinichi ^b   Watanabe, Akihiro ^d   Kakeji, Yoshihiro ^b   Sugimachi, Keizo ^a,b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NATIONAL KYUSHU CANCER CENTER   (Japan)

^d NHO Saga Hospital   (Japan)

Author keywords

Gastric cancer; Metalloproteinases; One step sandwich immunoassay (EIA); Serum and plasma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GELATINASE A; GELATINASE B; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PLASMA; PRIORITY JOURNAL; SERUM; STOMACH CANCER;

ADENOCARCINOMA; AGED; CARCINOEMBRYONIC ANTIGEN; CHI-SQUARE DISTRIBUTION; COLLAGENASES; ENZYME PRECURSORS; FEMALE; GELATINASES; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REFERENCE VALUES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030800319     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Shimizu N, Wakatsuki T, Murakami A, Yoshioka H, Hamazoe R, Kanayama H, Maeta M and Koga S: Carcinoembryonic antigen in gastric cancer patients. Oncology 44: 240-244, 1987.
2. Heptner G, Domschke S and Domschke W: Comparison of CA72-4 with CA19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies. Scand J Gastroenterol 24: 745-750, 1989.
3. Maeta M, Yoshioka H, Shimizu T, Murakami A, Hamazoe R and Koga S: Carbohydrate antigen 19-9 in tissues and sera from patients with gastric cancer. Oncology 47: 229-233, 1990.
4. Nishida K, Yamamoto T, Yoshioka K, Iida M, Miyagawa H, Yoshikawa T, Sugino S and Kondo M: Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer (in Japanese with English abstract). Jpn J Cancer Chemother 13: 101-108, 1986.
5. Takahashi I, Maehara Y, Kusumoto T, Yoshida M, Kakeji Y, Kusumoto H, Furusawa M and Sugimachi K: Predictive value of preoperative serum sialyl Tn antigen levels in prognosis of patients with gastric cancer. Cancer 72: 1836- 1840, 1993.
6. Takahashi I, Maehara Y, Kusumoto T, Kohnoe S, Kakeji Y, Baba H and Sugimachi K: Combined evaluation of preoperative serum sialyl- Tn antigen and carcinoembryonic antigen levels is prognostic for gastric cancer patients. Br J Cancer 69: 163-166, 1994.
7. Quentmeier A, Schlag P, Geisen HP and Schmidt-Gayk H: Evaluation of Ca 12-5 as a tumor marker for gastric and colorectal cancer in comparison to CEA and Ca 19-9. Eur J Surg Oncol 13: 197- 201, 1987.
8. Kornek G, Depisch D, Temsch EM and Scheithauer W. Comparative analysis of cancer-associated antigen CA- 195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer. J Cancer Res Clin Oncol 117: 493-496, 1991.
9. Liotta LA, Steeg PA and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
10. Brown PD, Bloxidge RE, Stuart, NSA, Gatter KC and Carmichael J: Association between expression of activated 72-kilodalton gelatinase and tumor spread in non small cell lung carcinoma. J Natl Cancer Inst 85: 574-578, 1994.
11. Shima I, Sasaguri Y, Kusukawa J, Nakano R, Yamana H, Fujita H, Kakegawa T, and Morimatsu M: Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor, Br J Cancer 67: 721-727, 1990.
12. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Handy A and Balkwill F: Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365-5369, 1993.
13. Macdougall JR, Bani MR, Lin Y, Rak J and Kerbel RS: The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 55: 4174-4181, 1995.
14. Zucker S, Lysik RM, Zarrabi MH and Moll U: Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 53: 140-146, 1993.
15. Garbisa S, Scagliotti G, Masiero L, Francesco CD, Caenazzo C, Onisto M, Micela M, Stetler-Stevenson WG and Liotta LA: Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res 52: 4548-4549, 1992.
16. Nakajima M, Welch DR, Wynn DM, Tsuruo T and Nicolson GL: Serum and plasma Mr 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res 53: 5802-5807, 1993.
17. Fujimoto N, Mouri N, Iwata K, Obuchi E, Shinya T and Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 231: 79-88, 1994.
18. Fujimoto N, Mouri N, Iwata K, Obuchi E, Okada Y and Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 221: 91-103, 1993.
19. Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study in surgery and pathology: Part I and Part II. Jpn J Surg 11: 127-145, 1981.
20. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S and He C: Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2. Proc Natl Acad Sci USA 86: 8207-8211, 1989.
21. Howard EW, Bullen EC and Banda MJ. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinase-2. J Biol Chem 266: 13064-13069, 1991.
22. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K and Hayakawa T: Matrix metalloproteinase 9(92 kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells: purification and activation of the precursor, and enzymic properties. J Biol Chem 267: 21712-21719, 1992.
23. Maehara Y, Sugimachi K, Akagi M, Kakegawa T, Shimazu H and Tomita M: Serum carcinoembryonic antigen level increases correlate with tumor progression in patients with differentiated gastric carcinoma following noncurative resection. Cancer Res 50: 3952-3955, 1990.
24. Kleiner DJ and Stetler-Stevenson WG: Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol 5: 891-897, 1993.
25. Brown PD, Kleiner DE, Unsworth EJ and Stetler-Stevenson WG: Cellular activation of the 72kDa type IV procollagenase/TIMP-2 complex. Kidney Int 43:163-170, 1993.
26. Strongin AY, Marmer BL, Grant GA and Goldberg GI: Plasma membrane-dependent activation of the 72kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 268: 14033-14039, 1993.
27. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase express in the surface of tumor cells. Nature (Lond.) 370: 61-65, 1994.
28. Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y and Seiki M: Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 64: 355-359, 1995.
29. Gilles C, Polette M, Piette J, Munaut C, Thompson EW, Birembaut P and Foidaut J-M: High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 65: 209-213, 1996.
30. Okada A, Bellocq Jean-Pierre, Rouyer N, Chenard Marie-Pierre, Rio Marie-C, Chambon P and Basset P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92: 2730-2734, 1995.
31. Nomura H, Sato H, Seiki M, Mai M and Okada Y: Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55: 3263-3266, 1995.
32. Nakajima M, Morikawa K, Fabra A, Bucana CD and Fidler IJ: Influence of organ environment on the extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82: 1890-1898, 1988.
33. Welch DR, Fabra A and Nakajima M: Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastaric potential. Proc Natl Acad Sci USA 87: 7678-7682, 1990.